BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8206190)

  • 1. [Standardized ambulatory insulin therapy of initial moderate ketoacidosis in type 1 diabetes. A pilot project].
    Estour B; Fourel E; Voitellier P; Millot L; Rachidi H; Vergely N; Ghervan C
    Diabete Metab; 1993 Dec; 19(5 Suppl):514-7. PubMed ID: 8206190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Our experience in continuous administration of insulin using infusion dispenser at a metabolic intensive care unit (MICU)].
    Charvát J; Pálová S; Horácková M; Kratochvíl J; Masopust J
    Vnitr Lek; 2007 Oct; 53(10):1047-52. PubMed ID: 18072428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient or outpatient initiation of insulin therapy. Experience and cost effective analysis in a suboptimal clinical setting.
    Mengistu M; Lungi Y; Mamo F
    Trop Geogr Med; 1991; 43(1-2):180-3. PubMed ID: 1750112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outpatient adjustment to insulin in patients with diabetes mellitus].
    van Ballegooie E; Offerman JJ; Casparie AF; Israël-Bultman H
    Ned Tijdschr Geneeskd; 1990 Jan; 134(2):68-70. PubMed ID: 2404212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
    Pfützner J; Forst T; Butzer R; Forst S; Weber MM; Pfützner AH; Pfützner A
    Diabet Med; 2006 Oct; 23(10):1124-9. PubMed ID: 16978378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic ketoacidosis during insulin pump therapy].
    Walter H; Günther A; Timmler R; Mehnert H
    Dtsch Med Wochenschr; 1989 May; 114(18):706-8. PubMed ID: 2496965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
    Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
    Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic control with insulin pump therapy: the Waikato experience.
    Reda E; Von Reitzenstein A; Dunn P
    N Z Med J; 2007 Jan; 120(1248):U2401. PubMed ID: 17277817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
    Berhe T; Postellon D; Wilson B; Stone R
    Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ketoacidosis in long-term therapy with insulin pumps. Incidence, causes, circumstances].
    Walter H; Günther A; Timmler R; Mehnert H
    Med Klin (Munich); 1989 Dec; 84(12):565-8. PubMed ID: 2516236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences.
    Newton CA; Raskin P
    Arch Intern Med; 2004 Sep; 164(17):1925-31. PubMed ID: 15451769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin infusion in diabetic ketoacidosis.
    Sachdev Y
    Indian Pediatr; 1983 Oct; 20(10):747-52. PubMed ID: 6427105
    [No Abstract]   [Full Text] [Related]  

  • 20. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
    Shashaj B; Busetto E; Sulli N
    Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.